Chemoinformaics analysis of meso-dihydroguaiaretic-acid
| Molecular Weight | 768.982 | nRot | 7 |
| Heavy Atom Molecular Weight | 700.438 | nRig | 25 |
| Exact Molecular Weight | 768.466 | nRing | 7 |
| Solubility: LogS | -6.146 | nHRing | 3 |
| Solubility: LogP | 7.153 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 122 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 68 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 41 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
| nHA | 13 | APOL | 124.238 |
| nHD | 8 | BPOL | 76.8981 |
| QED | 0.421 |
| Synth | 4.751 |
| Natural Product Likeliness | 3.307 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.377 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.903 |
| MDCK | 0.00000751 |
| BBB | 0.664 |
| PPB | 0.99673 |
| VDSS | 1.773 |
| FU | 0.0159372 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.429 |
| CYP2c19-inh | 0.065 |
| CYP2c19-sub | 0.968 |
| CYP2c9-inh | 0.079 |
| CYP2c9-sub | 0.283 |
| CYP2d6-inh | 0.051 |
| CYP2d6-sub | 0.74 |
| CYP3a4-inh | 0.141 |
| CYP3a4-sub | 0.652 |
| CL | 18.462 |
| T12 | 0.008 |
| hERG | 0.007 |
| Ames | 0.017 |
| ROA | 0.228 |
| SkinSen | 0.057 |
| Carcinogencity | 0.023 |
| EI | 0.097 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.551 |
| Antiviral | Yes |
| Prediction | 0.850488 |